18 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... -19 Specific Medications ... Respiratory Cardiac Hematologic ... NonIntensivist #diagnosis #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Prophylaxis) Indication ... PO once daily Indication ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Causes of Neutrophilia - Increased Neutrophils - Differential Diagnosis Algorithm
Infection
 • Bacterial
 • Abscess
 • Viral
Medications
Differential Diagnosis Algorithm ... Infection • ... Abscess • Viral Medications ... pancytopenia, blast cells ... #Causes #Hematology
Eosinophil Disorders Testing Algorithm
INDICATIONS FOR TESTING:
 • Peripheral blood eosinophilia/hypereosinophilia uncovered incidentally during medical evaluation or
Disorders Testing Algorithm ... INDICATIONS FOR ... drug reaction, infection ... Strongyloides infection ... Differential #diagnosis #hematology
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... 12 000 or <400 cells ... approved for this indication ... #SSTIs #Algorithm
Acute Diarrhea - Differential Diagnosis Framework
1)  Diagnostic studies only for dysentery, severe disease, >7 days
2)
recommended Infectious ... , Cystisospora belli ... : Medications, Acute ... NonInfectious #Algorithm ... #gastroenterology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... -6 activates T cells ... respiratory tract infection ... #Pharmacology #Management ... #Medications
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis Indication ... CD4 count <200 cells ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Neutropenia - recurrent infections ... - Antithyroid medications ... Idiopathic • Infections ... Anemia #oncology #hematology ... #diagnosis #management
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
lymphocytes, smudge cells ... Complications: 1) Infection ... low-risk disease • Indications ... Leukemia #oncology #hematology ... hemeonc #diagnosis #management